Medicure Inc. (OTCMKTS:MCUJF – Get Rating) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 200 shares, a growth of 100.0% from the August 15th total of 100 shares. Based on an average trading volume of 14,900 shares, the short-interest ratio is presently 0.0 days.
Medicure Price Performance
Shares of OTCMKTS MCUJF remained flat at $0.83 during trading hours on Thursday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.47 and a quick ratio of 1.16. The firm has a 50 day moving average of $0.80 and a 200-day moving average of $0.84. The company has a market cap of $8.51 million, a P/E ratio of 13.84 and a beta of 0.88. Medicure has a 1-year low of $0.64 and a 1-year high of $1.10.
Get Medicure alerts:About Medicure
(Get Rating)
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.See Also
- Get a free copy of the StockNews.com research report on Medicure (MCUJF)
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
- 2 Reasons Netflix Might Have Just Bottomed Out
- Has 3M Reached the Point of Being so Bad It's Good?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.